Recent Finacing
Recent Raise
Fuse Vectors operates a cell-free, enzymatic AAV capsid-filling manufacturing platform for viral gene therapies, using a modular library for on-demand biocatalytic reactions compatible across AAV serotypes.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Fuse Vectors.
